Please use this identifier to cite or link to this item:
Title: Pharmaceutical development based on quality by design
Authors: Mariano, Diana Isabel Salgado
Orientador: Sousa, João José Martins Simões
Keywords: Indústria farmacêutica; Tecnologia farmacêutica; Controlo de qualidade; Preparações farmacêuticas; Desenho de fármacos
Issue Date: Sep-2015
Place of publication or event: Coimbra
Abstract: The main objective of a pharmaceutical industry is to develop a harmonised pharmaceutical quality system applicable across the lifecycle of the product emphasizing an integrated approach to quality risk management and science. The strategic approach for product development is a choice of applicant and he may choose for minimal approach or a more systematic approach, also defined as Quality by Design (QbD). The minimal approach is an empirical development with one variable at a time fixed manufacturing process and focused on reproducibility, so quality is assured by testing and management is a reactive lifecycle, in other words corrective actions. [1] With the development of technology and the pharmaceutical industry emerged a more complete approach, QbD, to ensure the quality, efficacy and safety of drug product. QbD is an approach that aims to ensure the quality of medicines by employing statistical, analytical and risk-management methodology in the design, development and manufacturing of medicines. One of the goals of QbD is to ensure that all sources of variability affecting a process are identified, explained and managed by appropriate measures. This enables the finished medicine to consistently meet its predefined characteristics from the start. QbD centers on the use of multivariate analysis, often in combination with modern processanalytical chemistry methods and knowledge-management tools to enhance the identification and understanding of critical attributes of materials and critical parameters of the manufacturing process adjustable within the design space. This enhanced understanding of product and process is used to build quality into manufacturing and provides the basis for continuous improvement of products and processes. [2] Both approaches are acceptable, but QbD is preferable and provides the basis for flexible regulatory approaches.
Description: Monografia realizada no âmbito da unidade Estágio Curricular do Mestrado Integrado em Ciências Farmacêuticas, apresentada à Faculdade de Farmácia da Universidade de Coimbra
Rights: openAccess
Appears in Collections:FFUC- Teses de Mestrado

Files in This Item:
File Description SizeFormat
Diana Mariano - Monografia.pdf21.24 MBAdobe PDFView/Open
Show full item record

Page view(s)

checked on Sep 22, 2020


checked on Sep 22, 2020

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.